Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $2.00B.
ENTERPRISE VALUE (EV)
$2.00B
Dyne Therapeutics, Inc.
Market Cap
$2.88B
Enterprise Value (EV)
$2.00B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Dyne Therapeutics, Inc. (DYN) | $2.88B | $2.00B |
| TransMedics Group, Inc. (TMDX)vs › | $2.82B | $3.22B |
| AtriCure, Inc. (ATRC)vs › | $2.79B | $2.70B |
| Precigen, Inc. (PGEN)vs › | $2.74B | $2.82B |
| MBX Biosciences, Inc. Common Stock (MBX)vs › | $2.72B | $2.67B |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.70B | $5.09B |
| Neogen Corporation (NEOG)vs › | $2.69B | $3.30B |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.69B | $4.09B |
| Enliven Therapeutics, Inc. (ELVN)vs › | $3.07B | $2.94B |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.08B | $3.03B |
Market Cap
$2.88B
Total Debt
$20.28M
Cash
$893.37M
Enterprise Value
$2.00B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
